Quince Therapeutics Inc

Research Quince Therapeutics Inc (QNCX) on Bullrun: market cap USD 15.01M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerQNCX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 15.01M
• Financial periodFY2025
• Net income-USD 83.98M
• Free cash flow-USD 41.78M

Valuation Snapshot

latest market cap is USD 15.01M.

About Quince Therapeutics Inc

Quince Therapeutics, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises eDSP, which is in Phase 3, for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in ATM gene.

Frequently asked questions

What is Quince Therapeutics Inc's market cap?

Quince Therapeutics Inc's market capitalization is USD 15.01M.

What does Quince Therapeutics Inc do?

Quince Therapeutics, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases.